The DOI matches its Crossref record.
Ornithine decarboxylase as a target for chemoprevention
Abstract
l-Ornithine decarboxylase (ODC) is essential for polyamine synthesis and growth in mammalian cells; it provides putrescine that is usually converted into the higher polyamines, spermidine and spermine. Many highly specific and potent inhibitors of ODC are based on the lead compound α-difluoromethylornithine (DFMO), which is an enzyme-activated irreversible inhibitor. DFMO is accepted as a substrate by ODC and is decarboxylated, leading to the formation of a highly reactive species that forms a covalent adduct with either cysteine-360 (90%) or lysine-69 (10%). Both modifications inactivate the enzyme. ODC activity is normally very highly regulated at both transcriptional and post-transcriptional levels according to the growth state of the cell and the intracellular polyamine content. Experimental over-production of ODC can be caused by either transfection with plasmids containing the ODC cDNA with part of the 5′-untranslated region (5′UTR) deleted under the control of a very strong viral promoter, or transfection of plasmids that cause the overproduction of eIF-4E, reported to be a limiting factor in the transaltion of mRNAs with extensive secondary structures in the 5′UTR. In both cases, unregulated overexpresion of ODC transforms NIH 3T3 cells to a neoplastic state. Along with studies showing that many tumor promoters increase ODC activity and that a number of preneoplasic conditions and tumor samples show high levels of ODC, these results suggest that ODC may act as an oncogene in an appropiate background. This provides a rationale for the possible use of a ODC inhibitors as chemopreventive agents. Further support comes from studies showing that reducing ODC activity with DFMO abolishes the transformed phenotype of the NIH 3T3 cells overexpressing ODC; many studies found that treatment with DFMO reduces tumor incidence in experimental animal exposed to carcinogens. Although these results provide strong support for initial testing of DFMO as a chemopreventive agents, other means of reducing ODC activity should not be overlooked, including the use of other enzyme-acivated irreversible inhibitors with higher potency and/or better pharmacokinetics than DFMO, use of dominant negative mutations or ribzymes to reduce actic ODC levels, and use of regulator of ODC expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Ignarro, L. J., Buga, G. M., Wei, L. H., Bauer, P. M., Wu, G., & del Soldato, P. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.071054698 · Cited by 331
Biogenic Amines in Dairy Products: Origin, Incidence, and Control Means
Benkerroum, N. (2016) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12212 · Cited by 254
Polyamine depletion inhibits the autophagic response modulatingTrypanosoma cruziinfectivity
Vanrell, M. C., Cueto, J. A., Barclay, J. J., Carrillo, C., Colombo, M. I., Gottlieb, R. A., & Romano, P. S. (2013) · Autophagy · doi:10.4161/auto.24709 · Cited by 39
Metadata
- Authors
- Pegg, A. E., Shantz, L. M., & Coleman, C. S.
- Venue
- Journal of Cellular Biochemistry
- Publisher
- Wiley
- Published
- 1995
- Volume
- 59
- Issue
- S22
- Pages
- 132-138
- ISSN
- 0730-2312 (ISSN-L)
- 1097-4644
- OpenAlex
- W2112588931
- Cited by
- 167
- References
- 0
- FWCI
- 1.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ornithine decarboxylase as a target for chemoprevention. https://app.cochat.ai/papers/10.1002/jcb.240590817
- The paper
- Pegg, A. E., Shantz, L. M., & Coleman, C. S. (1995). Ornithine decarboxylase as a target for chemoprevention. Journal of Cellular Biochemistry. https://doi.org/10.1002/jcb.240590817
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.